Abstract
Although early treatment with intravenous immunoglobulin reduces the risk of coronary artery aneurysms, in refractory cases of Kawasaki disease, myocardial infarction can result from thrombosis of coronary artery aneurysms. Early recognition of myocardial infarction from Kawasaki disease myocarditis can reduce morbidity and mortality. This report describes successful treatment of myocardial infarction from coronary thrombosis in an infant with Kawasaki disease using intravenous tissue plasminogen activator and abciximab.
Original language | English (US) |
---|---|
Pages (from-to) | 255-259 |
Number of pages | 5 |
Journal | Seminars in Cardiothoracic and Vascular Anesthesia |
Volume | 19 |
Issue number | 3 |
DOIs | |
State | Published - Sep 21 2015 |
Keywords
- Kawasaki disease
- abciximab
- coronary artery aneurysms
- coronary artery thrombosis
- myocardial infarction
- thrombolytics
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Anesthesiology and Pain Medicine